J&J Confide home-HIV test ownership to be decided by arbitrator.
This article was originally published in The Tan Sheet
CONFIDE HIV TEST OWNERSHIP HANGS ON ARBITRATION DECISION, which could be handed down in 30 days once attorneys for Johnson & Johnson and former Direct Access Diagnostics President and CEO Elliott Millenson comply with an arbitrator's request for additional information in the wrongful dismissal suit. Former U.S. Court of Appeals Judge John Gibbons, a Newark, New Jersey-based arbitrator for the American Arbitration Association, decided in favor of Millenson on July 16 and asked both parties to submit "remedy" briefs by the week of July 22 to resolve the status of the Confide assets.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC